Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silkworm Pupa Tablets for Nutritional Status and Sarcopenia in Malignancies
NCT07554807Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Sarcopenia and Nutritional deficiency (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Sarcopenia prevalence at 3 months. Planned start Apr 2026; status: not yet recruiting.
02
Conditions
SarcopeniaNutritional deficiency
Beyond the preview
Go deeper on NCT07554807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07554807.